Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04849780 · ClinicalTrials.gov registry record · NA

Evaluation of Dryness in a Silicone Hydrogel Daily Disposable Contact Lens

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
95
Enrollment target
9
Study locations

NCT04849780: Completed NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

NCT04849780 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 95 participants, below the 135-participant average among 20 other Visual Acuity trials with a reported enrollment target (30% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04849780, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target
9
Study locations

Study Summary

This is a multi-site, randomized, bilateral, dispensing, parallel design study with two arms to evaluate contact lens related dry eye symptoms and subjective comfort.

Primary Outcome

Comfort was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive r

Conditions Studied

Interventions

  • DEVICE ACUVUE Oasys 1-Day
  • DEVICE Habitual Lens

Study Locations (9)

Florida

  • Vue Optical Boutique - Jacksonville
  • Sabal Eye Care - Longwood
  • Maitland Vision Center - Maitland

Kansas

  • Kannarr Eye Care - Pittsburg

New York

  • Sacco Eye Group - Vestal

Ohio

  • Procare Vision Centers - Granville

Rhode Island

  • Dr. David Ferris & Associates - Warwick

Tennessee

  • Optometry Group Pllc - Memphis

Texas

  • Tyler Eye Associates - Tyler

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2021-04-17
Est. Completion 2021-08-12
Phase NA
Johnson & Johnson Vision Care

142 total trials

What the finished NCT04849780 record still lists

NCT04849780 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 135-participant average among 20 other Visual Acuity trials with a reported enrollment target (30% lower).

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which ACUVUE Oasys 1-Day is the first listed.

NCT04849780 lists 9 locations in 7 states (Florida, Kansas, New York).

Frequently Asked Questions

What is clinical trial NCT04849780 about?

NCT04849780 is a clinical study titled "Evaluation of Dryness in a Silicone Hydrogel Daily Disposable Contact Lens". This is a multi-site, randomized, bilateral, dispensing, parallel design study with two arms to evaluate contact lens related dry eye symptoms and subjective comfort.

What is the current status of trial NCT04849780?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2021-04-17. Estimated completion is 2021-08-12.

What conditions does trial NCT04849780 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT04849780?

The interventions under investigation include: ACUVUE Oasys 1-Day (DEVICE), Habitual Lens (DEVICE).

Who is sponsoring clinical trial NCT04849780?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04849780 being conducted?

This trial has 9 study locations across Florida, Kansas, New York, Ohio, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04849780's enrollment target sits among peer trials

95 10th of 20 higher than 10 of 20 other Visual Acuity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Visual Acuity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04849780, the US trial registry maintained by the National Library of Medicine. NCT04849780 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.